Background:
Chest pain is a common reason for parents
to seek medical attention for their children.
Annually, physicians evaluate approximately
650,000 cases of chest pain in patients aged 10-21
years, a number that may reflect overwhelming
concern about chest pain as a manifestation of
cardiac disease and cancer in older patients.
Costochondritis is a common cause of chest pain
in children and adolescents. The condition is
characterized as an inflammatory process of 1 or
more of the costochondral cartilages that causes
localized tenderness and pain of the anterior
chest wall. Most cases of costochondritis are
idiopathic. The remaining cases may result from
costochondral irritation due to direct trauma,
aggressive exercise that caused a strain, or a
prior upper respiratory tract infection with cough
that caused repeated stretching and strain at the
costochondral junction.
Costochondritis is a relatively benign and
usually self-limited condition. Patients often are
evaluated initially in the ED or, with acute
conditions, in their primary care physician's
office.
The term Tietze syndrome implies swelling;
costochondritis refers to pain alone.
Pathophysiology:
The exact
pathophysiology of cartilage and capsular
involvement is unknown because costochondritis
does not warrant surgical intervention or tissue
biopsy. Theoretically, the cartilage involved in
costochondritis is either inflamed or torn. Either
condition presumably leads to inflammation with
subsequent stimulation of pain receptors.
Frequency:
- In the US:
Several studies
of chest pain in pediatric patients report
costochondritis prevalences of 14-30%; a single
study reported rates as high as 79%. The overall
incidence rate is approximately 4% of children
and adolescents.
Mortality/Morbidity:
No
reports have associated mortality with
costochondritis, and no mortality is expected.
Race:
A study indicates
Hispanics may have a higher incidence of
costochondritis, but most studies do not mention
race as a factor.
Sex:
Studies of chest pain in
children found that females are diagnosed with
costochondritis more often than males by a 2:1
ratio.
Age:
No data support an
association between age and costochondritis; the
condition is well described in children of all
ages, including infants.
History:
The key to the diagnosis of
costochondritis amid the differential diagnoses,
which include cardiac and pulmonary disease, is a
thorough history and physical examination.
- Presenting characteristics of chest pain
associated with costochondritis
- Onset - Typically insidious, occurring
over several days or weeks, may be acute
- Nature - Sharp and stabbing
- Location - Anterior chest, pain usually
unilateral, but may be bilateral
- Radiation - Chest, upper abdomen, or back
- Exacerbating factors - Coughing, sneezing,
deep inspirations, movement of the upper torso
and upper extremities
- Relieving factors - Rest, application of
ice, or use of heat
- Preceding conditions - Upper respiratory
tract infection or exercise (common in
preceding 3 mo)
Physical:
Vital signs should
be assessed. Careful and complete pulmonary,
cardiac, and abdominal examinations eliminate the
possibility of an underlying disease process.
- Inspection focuses on symmetry of the chest
wall. Asymmetry may indicate trauma as a cause
of chest pain.
- Swelling is uncommon. Patients with Tietze
syndrome, however, may have swelling over an
upper costochondral junction.
- Ecchymosis would be expected only in trauma.
- Respiratory effort is normal.
- Palpation that reveals tenderness over the
costochondral junction is diagnostic. The
tenderness should be localized and is most
common at the sternocostal cartilage of the
second through the seventh ribs.
- Examination may be performed with firm,
single-digit palpation of the area.
- Crepitus is uncommon and may indicate a
fracture.
- Auscultation of the lungs, heart, and
abdomen are normal.
Causes:
Most cases of
costochondritis are idiopathic. The remaining
cases may be the result of costochondral
irritation caused by the following:
- Aggressive exercise resulting in a strain (eg,
repeated twisting of the upper torso,
stretching-pulling activities of the upper
extremities)
- Preceding upper respiratory tract infection
with cough (which can cause repeated stretching
and strain at the costochondral junction)
Drug Name
|
Ibuprofen
(Motrin, Advil, Ibuprin) -- Inhibits
inflammatory reactions and pain by decreasing
prostaglandin synthesis. |
| Adult Dose |
400-800
mg PO q6-8h prn |
| Pediatric Dose |
5-10
mg/kg PO q6-8h prn |
| Contraindications |
Documented hypersensitivity, known
hypersensitivity to aspirin or other NSAIDs;
active GI bleeding, active ulcer |
| Interactions |
Avoid
concomitant use of aspirin; may increase
bleeding with anticoagulants, increase
toxicity of methotrexate, and increase serum
lithium levels; may decrease effects of
furosemide or thiazide diuretics |
| Pregnancy |
B -
Usually safe but benefits must outweigh the
risks. |
| Precautions |
History
of upper GI disease, peptic ulcer, gastric
ulcer; impaired renal or hepatic function;
edema, hypertension; bleeding disorder;
diabetes; dehydration; pregnancy category D at
third trimester |
Drug Name
|
Naproxen
(Aleve) -- Available as OTC preparation and in
prescription form; OTC preparation has faster
onset of action, though limited duration of
action. Prescription form is available in both
pill and elixir forms and has a convenient
bid-dosing schedule. |
| Adult Dose |
200-500
mg PO bid prn |
| Pediatric Dose |
<2 years:
Not established
>2 years: 2.5-5 mg/kg PO q8-12h prn; not to
exceed 20 mg/kg/d or 1 g/d
|
| Contraindications |
Documented hypersensitivity, known
hypersensitivity to aspirin or other NSAIDs;
active GI bleeding, active ulcer |
| Interactions |
Avoid
concomitant aspirin; may potentiate
protein-bound drugs (eg, hydantoins,
sulfonamides, sulfonylureas); monitor PO
anticoagulants; may antagonize diuretics,
beta-blockers, other antihypertensives;
increased renal toxicity with ACE inhibitors;
reduces methotrexate excretion; increases
serum lithium levels |
| Pregnancy |
B -
Usually safe but benefits must outweigh the
risks. |
| Precautions |
Active
peptic ulcer; history of GI disease; impaired
renal or hepatic function; heart failure;
edema; hypertension; monitor blood, hepatic,
renal, and ocular function with long-term use;
pregnancy category D at third trimester |
Drug Name
|
Acetaminophen (Tylenol) -- May be used to
relieve mild to moderate pain. Inhibits
prostaglandin synthetase in the CNS by
inhibiting cyclooxygenase. |
| Adult Dose |
650-1000
mg PO q6-8h prn; not to exceed 4 g/d |
| Pediatric Dose |
10-15
mg/kg PO q6-8h prn; not to exceed 2.6 g/d
|
| Contraindications |
Documented hypersensitivity; G-6-PD deficiency
|
| Interactions |
Rifampin
can interact to reduce analgesic effects;
conversely, barbiturates, carbamazepine,
hydantoins, isoniazid, may increase
hepatotoxicity |
| Pregnancy |
B -
Usually safe but benefits must outweigh the
risks. |
| Precautions |
Hepatotoxicity reported with high or chronic
dosing; severe or recurrent pain or high or
continued fever may indicate a serious
illness; contained in many OTC products and
combined use with these products may result in
cumulative doses exceeding recommended maximum
dose |
Drug Name
|
Tramadol
hydrochloride (Ultram) -- Inhibits ascending
pain pathways, altering perception of and
response to pain. Inhibits also reuptake of
norepinephrine and serotonin. |
| Adult Dose |
Gradually
titrate upward over 3 d to 50-100 mg PO q4-6h;
not to exceed 400 mg/d |
| Pediatric Dose |
<16
years: Not recommended
>16 years: Administer as in adults
|
| Contraindications |
Documented hypersensitivity; acute
intoxication with alcohol; hypnotics,
analgesics, opioids, or psychotropic drugs
dependence |
| Interactions |
Do not
use concomitantly with MAOIs; may potentiate
seizure risk with use of MAOIs, SSRIs,
tricyclics, neuroleptics, and opioids; use
caution when administering with other
depressants; may potentiate digoxin activity;
may be potentiated with concomitant use of
CYP2D6 inhibitors (eg, quinidine, fluoxetine,
paroxetine, amitriptyline) |
| Pregnancy |
C -
Safety for use during pregnancy has not been
established. |
| Precautions |
Initiate
dose gradually to minimize nausea and
vomiting; can cause dizziness, nausea,
constipation, sweating, pruritus; additive
sedation with alcohol and TCAs; abrupt
discontinuation can precipitate opioid
withdrawal symptoms; adjust dose in liver
disease, myxedema, hypothyroidism,
hypoadrenalism; pregnancy, breastfeeding;
seizure; development of tolerance or
dependency with extended use |